News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,604 Results
Type
Article (41588)
Company Profile (261)
Press Release (668755)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (207043)
Career Advice (2049)
Deals (35660)
Drug Delivery (98)
Drug Development (82008)
Employer Resources (175)
FDA (16316)
Job Trends (15080)
News (349633)
Policy (33045)
Tag
Academia (2658)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (50322)
ALS (95)
Alzheimer's disease (1412)
Antibody-drug conjugate (ADC) (133)
Approvals (16310)
Artificial intelligence (271)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11748)
BIOSECURE Act (20)
Biosimilars (108)
Biotechnology (182)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (293)
Cancer (2335)
Cardiovascular disease (183)
Career advice (1717)
Career pathing (31)
CAR-T (156)
Cell therapy (441)
Cervical cancer (20)
Clinical research (66711)
Collaboration (866)
Company closure (2)
Compensation (557)
Complete response letters (20)
COVID-19 (2659)
CRISPR (43)
C-suite (259)
Cystic fibrosis (103)
Data (2316)
Decentralized trials (2)
Denatured (19)
Depression (46)
Diabetes (278)
Diagnostics (6477)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (123)
Drug pricing (103)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87328)
Editorial (41)
Employer branding (22)
Employer resources (149)
Events (114476)
Executive appointments (750)
FDA (17690)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (785)
Gene editing (111)
Generative AI (22)
Gene therapy (317)
GLP-1 (737)
Government (4506)
Grass and pollen (4)
Guidances (150)
Healthcare (19091)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2806)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (316)
IPO (16591)
IRA (40)
Job creations (3746)
Job search strategy (1460)
Kidney cancer (11)
Labor market (43)
Layoffs (487)
Leadership (18)
Legal (8065)
Liver cancer (78)
Lung cancer (326)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (326)
MASH (74)
Medical device (13504)
Medtech (13509)
Mergers & acquisitions (19641)
Metabolic disorders (711)
Multiple sclerosis (83)
NASH (17)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (1970)
NextGen: Class of 2025 (6604)
Non-profit (4620)
Now hiring (40)
Obesity (376)
Opinion (207)
Ovarian cancer (80)
Pain (93)
Pancreatic cancer (89)
Parkinson's disease (153)
Partnered (21)
Patents (241)
Patient recruitment (116)
Peanut (46)
People (58712)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20797)
Phase II (29369)
Phase III (21866)
Pipeline (1349)
Policy (149)
Postmarket research (2605)
Preclinical (8929)
Press Release (67)
Prostate cancer (107)
Psychedelics (32)
Radiopharmaceuticals (248)
Rare diseases (387)
Real estate (6024)
Recruiting (67)
Regulatory (22615)
Reports (47)
Research institute (2423)
Resumes & cover letters (353)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (70)
Series A (136)
Series B (89)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3676)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (48)
The Weekly (32)
Vaccines (709)
Venture capitalists (42)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Last 7 days (939)
Last 30 days (3005)
Last 365 days (32705)
2025 (11792)
2024 (35646)
2023 (40536)
2022 (51688)
2021 (56273)
2020 (54653)
2019 (47239)
2018 (35601)
2017 (32703)
2016 (32178)
2015 (38225)
2014 (31919)
2013 (26973)
2012 (29100)
2011 (29764)
2010 (27847)
Location
Africa (745)
Alabama (55)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38573)
Australia (6338)
California (6399)
Canada (2076)
China (536)
Colorado (272)
Connecticut (284)
Delaware (156)
Europe (84180)
Florida (947)
Georgia (214)
Idaho (57)
Illinois (555)
India (25)
Indiana (319)
Iowa (11)
Japan (172)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (70)
Maryland (929)
Massachusetts (4799)
Michigan (224)
Minnesota (410)
Mississippi (2)
Missouri (82)
Montana (28)
Nebraska (25)
Nevada (67)
New Hampshire (64)
New Jersey (1788)
New Mexico (30)
New York (1806)
North Carolina (1014)
North Dakota (9)
Northern California (2814)
Ohio (214)
Oklahoma (14)
Oregon (37)
Pennsylvania (1424)
Puerto Rico (14)
Rhode Island (34)
South America (1130)
South Carolina (25)
South Dakota (1)
Southern California (2410)
Tennessee (107)
Texas (950)
United States (24091)
Utah (190)
Virginia (155)
Washington D.C. (64)
Washington State (567)
West Virginia (3)
Wisconsin (57)
710,604 Results for "safeguard scientifics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
May 8, 2025
·
4 min read
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.
May 2, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
Press Releases
Reflect Scientific Inc. Reports Strong Revenue Growth in 2024
March 20, 2025
·
3 min read
Pixium Vision announces the conversion of the safeguard proceedings into receivership
Pixium Vision SA announces the conversion of the safeguard proceedings which has been in place since October 9, 2023 into receivership.
November 13, 2023
·
2 min read
Press Releases
Syantra, Inc. Announces Chair of Scientific Advisory Board and New Members
February 11, 2025
·
4 min read
Press Releases
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
February 25, 2025
·
4 min read
Genetown
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks.
May 30, 2024
·
4 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
January 8, 2025
·
7 min read
Press Releases
Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B
February 26, 2025
·
6 min read
1 of 71,061
Next
